Chi Advisors LLC Black Diamond Therapeutics, Inc. Transaction History
Chi Advisors LLC
- $203 Million
- Q3 2023
A detailed history of Chi Advisors LLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Chi Advisors LLC holds 720,000 shares of BDTX stock, worth $1.8 Million. This represents 1.02% of its overall portfolio holdings.
Number of Shares
720,000
Previous 750,000
4.0%
Holding current value
$1.8 Million
Previous $3.79 Million
45.44%
% of portfolio
1.02%
Previous 1.42%
Shares
2 transactions
Others Institutions Holding BDTX
# of Institutions
117Shares Held
48.8MCall Options Held
1.84MPut Options Held
1.93M-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$26.8 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.52MShares$21.3 Million0.62% of portfolio
-
Vestal Point Capital, LP New York, NY5.03MShares$12.6 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$11.1 Million1.48% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$8.04 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $90.8M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...